Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 03, 2026
Why Exact Sciences Stock Is Soaring Today
11:23am, Friday, 04'th Nov 2022
Investors are reacting positively to the company's Q3 update.
Exact Sciences Corporation (EXAS) Q3 2022 Earnings Call Transcript
09:32pm, Thursday, 03'rd Nov 2022
Exact Sciences Corporation (NASDAQ:EXAS ) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Megan Jones - Associate Manager, IR Kevin Conroy - Chairman & CEO Jeffrey El
Exact Sciences (EXAS) Reports Q3 Loss, Tops Revenue Estimates
09:04pm, Thursday, 03'rd Nov 2022
Exact Sciences (EXAS) delivered earnings and revenue surprises of 23.64% and 4.45%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Exact Sciences to participate in November investor conferences
06:00am, Tuesday, 01'st Nov 2022
MADISON, Wis. , Nov. 1, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate
Exact Sciences: Price Is Yet To Catch Up As Management Draws Profitability Plans
08:33am, Thursday, 13'th Oct 2022
As EXAS continues shifting its business models from "growth at all costs" to "profitable growth" in response to rising capital costs, its sales will expand at a slower pace. Despite the expected norma
Exact Sciences schedules third quarter 2022 earnings call
06:00am, Monday, 10'th Oct 2022
MADISON, Wis. , Oct. 10, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its th
3 Cathie Wood Stocks That Are Too Cheap to Ignore
07:20pm, Friday, 07'th Oct 2022
It's tough to follow anyone's lead in investing in the stock market these days. Many top stock pickers, including Cathie Wood of ARK Invest, have had a terrible year in the equity markets.
7 Cheap Cathie Wood Stocks to Buy in October
07:00am, Monday, 03'rd Oct 2022
If you're looking for cheap Cathie Wood stocks to buy in October, you might want to stay away from the controversial portfolio manager's latest fund. On Sept.
3 Growth Stocks That Could Double Your Money, According to Wall Street
05:29am, Thursday, 29'th Sep 2022
Price targets on these stocks are miles above their present market values.
Here's Why Investors Should Hold Exact Sciences (EXAS) Stock
12:47pm, Wednesday, 28'th Sep 2022
Growth in Exact Sciences' (EXAS) legacy Screening business is attributable to Cologuard volume growth and contributions from the PreventionGenetics, Biomatrica and Oncoguard Liver products.
7 Nasdaq Stocks to Buy on the Dip or You'll Be Kicking Yourself Later
05:30pm, Wednesday, 21'st Sep 2022
For a few months, I've believed that both inflation and stocks were bottoming. Now prominent JPMorgan analyst Marko Kolanovic is making the same call.
Exact Sciences (EXAS) Cologuard Business Grows Amid Cost Woes
12:48pm, Tuesday, 20'th Sep 2022
Following the acquisitions of Paradigm and Ashion, Exact Sciences (EXAS) is now offering therapy selection tests for patients with advanced cancer.
Exact Sciences (EXAS) Down 25.3% Since Last Earnings Report: Can It Rebound?
01:09pm, Thursday, 01'st Sep 2022
Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock?
Exact Sciences to participate in September investor conference
06:00am, Thursday, 01'st Sep 2022
MADISON, Wis. , Sept. 1, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate
Here's Why You Should Retain Exact Sciences (EXAS) Now
01:32pm, Wednesday, 24'th Aug 2022
Investors are optimistic about Exact Sciences' (EXAS) better-than-expected results and robust Cologuard volumes.
